https://www.ono-usa.com/
ONO PHARMA USA, INC. is pursuing the clinical development of new drug candidates and aiming to commercialize in the US. ONO PHARMA USA, INC. was established as a US subsidiary of Ono Pharmaceutical Co., Ltd. (ONO) in 1998. ONO was founded in Osaka, Japan, in 1717. ONO is an R&D-oriented pharmaceutical company committed to discovering and developing “first-in-class” medicines, like nivolumab, an anti-PD-1 antibody drug, focusing on oncology, immunology, neurology, and specialty research.
https://onopharma.blob.core.windows.net/ono/ONO_Corporate_Handout_2021_Spread.pdf
Contact this Exhibitor